Welcoming the New Kid on the Block; A Phase IIb Study of DDFPe in Large Vessel Strokes
Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Trial
NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial
Dodecafluoropentane Improves Neurological Function Following Anterior Ischemic Stroke
DDFPe Extends Window for tPA Therapy in a Rabbit Stroke Model
DDFPe delays and reduces MRI markers of infarction in a rat stroke model
Multiple Applications of DDFPe Prevents Death in a Rabbit Stroke Model
A preliminary PET evaluation of DDFPe effects on rabbit brain hypoxia in stroke
DDFPe Decreases Stroke Size and Improves Neurological Scores in a Rat Stroke Model
Progress in Dodecafluoropentane Emulsion as a Neuroprotective Agent in a Rabbit Stroke Model
Dodecafluoropentane Emulsion Decreases Infarct Volume in a Rabbit Ischemic Stroke Model